TrialReader


Asan Medical Center Myocardial Infarction Registry

NCT03412435 — Recruiting, 5000 participants, Seung-Jung Park

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT03412435, acronym Asan-MI
StatusRecruiting
Study typeObservational
Enrollment5000 (Estimated)
SponsorSeung-Jung Park (Other); collaborators: CardioVascular Research Foundation, Korea
ConditionsMyocardial Infarction, Acute, Coronary Stenosis
Datesstart 2018-04-27, primary completion 2026-12-31 (estimated), completion 2031-12-31 (estimated), first posted 2018-01-26, last updated 2026-01-02
Locations1 site in South Korea

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Myocardial Infarction, Acute All trials for Coronary Stenosis

-Summary

This study evaluates long-term outcome of patients diagnosed as acute myocardial infarction and treated with medication, coronary artery bypass surgery and percutaneous coronary intervention in Asan medical center, Korea.

Expand all sections  ·  Collapse all

+Detailed description

This study will collect 3000 cases retrospectively and 2000 cases prospectively.

+Arms and interventions

ArmTypeInterventionsDescription
Myocardial infarctiondiagnosed as acute myocardial infarction and treated with medical treatment, coronary artery bypass surgery and percutaneous coronary intervention.

+Outcome measures

Primary outcomes

  • A composite event of all-cause death, non-fatal myocardial infarction and repeat revascularization [1 year]

Secondary outcomes

  • All cause death [5 year]
  • Cardiac death [5 year]
  • Myocardial infarction [5 year]
  • A composite event of all-cause death and myocardial infarction [5 year]
  • A composite event of cardiac death and myocardial infarction [5 year]
  • Repeat revascularization [5 year]
  • Stent thrombosis [5 year]: according to Academic Research Consortium (ARC) criteria
  • Stroke [5 year]: A stroke or cerebrovascular accident with loss of neurological function caused by an ischemic or hemorrhagic event with residual symptoms at least 24 hours after onset or leading to death.
  • Procedure success [7 days]: Successful percutaneous coronary intervention at the intended target lesion with final instant residual stenosis of less than 30% by quantitative coronary angiography (QCA) and no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.
  • Surgery success [7 days]: Successful surgery defines as no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.

+Eligibility

Sex: All, ages: 19 Years to any

Inclusion Criteria:

* All consecutive acute myocardial infarction patients diagnosed through coronary angiography

+Locations (1)

FacilityCityCountryStatus
Asan Medical CenterSeoulSouth KoreaRecruiting

My Notes